Grifols holder Mason Capital against potential Brookfield deal
Mason Capital opposes Grifols sale to Brookfield Asset Management, raising concerns about the potential acquisition in the ...
Philadelphia Phillies capital raise values the team at around $3 billion
The Philadelphia Phillies recently raised close to $500 million in capital from three new investors, according to two people ...
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...
Promising Pipeline and Financial Stability Drive Buy Rating for Xilio Therapeutics
Morgan Stanley analyst Michael Ulz has maintained their bullish stance on XLO stock, giving a Buy rating yesterday. Michael Ulz has given his ...
4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move
When it comes to pre-revenue biotechs, it's often a struggle to build an investment thesis beyond "if the medicine works, the ...
Business Insider18h
Oppenheimer Sticks to Its Hold Rating for Moderna (MRNA)
The company’s shares closed yesterday at $50.28. Olson covers the Healthcare sector, focusing on stocks such as Jasper Therapeutics, Amgen, and Viking Therapeutics. According to TipRanks, Olson has an ...